Paper8770880
Role of aldosterone in the remnant kidney model in the rat.
Greene EL and 2 others. J Clin Invest, 1996. Cited by 406 papers, by iCite.
Cite this record
ConductScience Library. Role of aldosterone in the remnant kidney model in the rat. Papers, record 8770880. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8770880
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aldosterone | Major topic |
| Kidney | Major topic |
| Kidney Diseases | Major topic |
| Adrenal Glands | |
| Angiotensin II | |
| Angiotensin-Converting Enzyme Inhibitors | |
| Animals | |
| Biphenyl Compounds | |
| Blood Pressure | |
| Body Weight | |
| Disease Models, Animal | |
| Enalapril | |
| Imidazoles | |
| Losartan | |
| Male | |
| Mineralocorticoid Receptor Antagonists | |
| Nephrectomy | |
| Organ Size | |
| Rats | |
| Rats, Sprague-Dawley | |
| Spironolactone | |
| Tetrazoles |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| DK 31437 | NIDDK NIH HHS | United States | R01DK031437 | PubMed and NIH |
Source NIH RePORTER
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT03206658 | Spironolactone on Acute Kidney Injury in Critically Ill Patients | Background |
Source ClinicalTrials.gov
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7040227 | Experimental aldosterone hypertension in the dog. | Hypertension | 1982 | https://conductscience.org/library/papers/7040227 | PubMed |
| 2 | 14476289 | Experimentally induced chronic renal insufficiency in the rat. | Lab Invest | 1962 | https://conductscience.org/library/papers/14476289 | PubMed |
| 3 | 8322780 | Hypertension-related renal injury: a major contributor to end-stage renal disease. | Am J Kidney Dis | 1993 | https://conductscience.org/library/papers/8322780 | PubMed |
| 4 | 1443130 | Membrane receptors for aldosterone: a novel pathway for mineralocorticoid action. | Am J Physiol | 1992 | https://conductscience.org/library/papers/1443130 | PubMed |
| 5 | 8262324 | Synthesis of type VI collagen by cultured glomerular cells and comparison of its regulation by glucose and other factors with that of type IV collagen. | Diabetes | 1994 | https://conductscience.org/library/papers/8262324 | PubMed |
| 6 | 3335644 | N-desulfated/acetylated heparin ameliorates the progression of renal disease in rats with subtotal renal ablation. | J Clin Invest | 1988 | https://conductscience.org/library/papers/3335644 | PubMed |
| 7 | 1618554 | Aldosterone enhances angiotensin II receptor binding and inositol phosphate responses. | Hypertension | 1992 | https://conductscience.org/library/papers/1618554 | PubMed |
| 8 | 1522231 | Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. | J Clin Invest | 1992 | https://conductscience.org/library/papers/1522231 | PubMed |
| 9 | 1453111 | Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. | J Lab Clin Med | 1992 | https://conductscience.org/library/papers/1453111 | PubMed |
| 10 | 2295515 | Calcium antagonists inhibit elevated potassium efflux from aorta of aldosterone-salt hypertensive rats. | Hypertension | 1990 | https://conductscience.org/library/papers/2295515 | PubMed |
| 11 | 1501409 | Effects of salt restriction on renal growth and glomerular injury in rats with remnant kidneys. | Kidney Int | 1992 | https://conductscience.org/library/papers/1501409 | PubMed |
| 12 | 1852112 | Rapid effects of mineralocorticoids on sodium-proton exchanger: genomic or nongenomic pathway? | Am J Physiol | 1991 | https://conductscience.org/library/papers/1852112 | PubMed |
| 13 | 7043053 | Plasma aldosterone concentrations in chronic renal disease. | Kidney Int | 1982 | https://conductscience.org/library/papers/7043053 | PubMed |
| 14 | 940276 | Pathogenesis of the glomerulopathy associated with renal infarction in rats. | Kidney Int | 1976 | https://conductscience.org/library/papers/940276 | PubMed |
| 15 | 6715546 | Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension. | J Clin Invest | 1984 | https://conductscience.org/library/papers/6715546 | PubMed |
| 16 | 399242 | Sodium, extracellular fluid volume, and cardiac output changes in the genesis of mineralocorticoid hypertension in the intact dog. | Hypertension | 1979 | https://conductscience.org/library/papers/399242 | PubMed |
| 17 | 7786835 | "Escape" of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: implications for therapy. | Cardiovasc Drugs Ther | 1995 | https://conductscience.org/library/papers/7786835 | PubMed |
| 18 | 3011863 | Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. | J Clin Invest | 1986 | https://conductscience.org/library/papers/3011863 | PubMed |
| 19 | 1731371 | Long-term control of arterial blood pressure. | Physiol Rev | 1992 | https://conductscience.org/library/papers/1731371 | PubMed |
| 20 | 6645212 | Animal model to study the effect of adrenal hormones on epithelial function. | Kidney Int | 1983 | https://conductscience.org/library/papers/6645212 | PubMed |
Cited by135
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 406 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42291564 | Residual risk in cardiovascular and renal diseases and the potential role of aldosterone synthase inhibitors. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42291564 | PubMed |
| 42121102 | Real-world effectiveness and safety of finerenone in diabetic kidney disease with preserved eGFR: a retrospective study in China. | BMC Nephrol | 2026 | https://conductscience.org/library/papers/42121102 | PubMed |
| 42009842 | Salt and chronic kidney disease. | Nat Rev Nephrol | 2026 | https://conductscience.org/library/papers/42009842 | PubMed |
| 41898268 | Rho/ROCK Signaling Pathway in Kidney Diseases: Mechanisms and Therapeutic Perspectives. | Biomedicines | 2026 | https://conductscience.org/library/papers/41898268 | PubMed |
| 41533467 | Finerenone in People with CKD, Type 2 Diabetes, and History of Nephrectomy. | Clin J Am Soc Nephrol | 2026 | https://conductscience.org/library/papers/41533467 | PubMed |
| 39781481 | Clinical implications of mineralocorticoid receptor overactivation. | Clin Kidney J | 2025 | https://conductscience.org/library/papers/39781481 | PubMed |
| 39595045 | Exploring the Spectrum of Comorbidities Associated with Primary Aldosteronism: Insights from a Large Real-World Case-Control Study. | Biomedicines | 2024 | https://conductscience.org/library/papers/39595045 | PubMed |
| 39448809 | Evaluating the effects of adrenalectomy and mineralocorticoid receptor antagonist on cardiac remodeling and diastolic function in patients with aldosterone-producing adenoma. | Hypertens Res | 2025 | https://conductscience.org/library/papers/39448809 | PubMed |
| 39347536 | New Perspectives on Obesity-Associated Nephropathy from Pathophysiology to Therapeutics: Revealing the Promise of GLP-1 RA Therapy. | Drug Des Devel Ther | 2024 | https://conductscience.org/library/papers/39347536 | PubMed |
| 39140032 | Plasma aldosterone concentrations elevation in hypertensive patients: the dual impact on hyperuricemia and gout. | Front Endocrinol (Lausanne) | 2024 | https://conductscience.org/library/papers/39140032 | PubMed |
| 38808486 | Mechanism of protective actions of sparsentan in the kidney: lessons from studies in models of chronic kidney disease. | Clin Sci (Lond) | 2024 | https://conductscience.org/library/papers/38808486 | PubMed |
| 38727287 | Unveiling Selected Influences on Chronic Kidney Disease Development and Progression. | Cells | 2024 | https://conductscience.org/library/papers/38727287 | PubMed |
| 38583123 | Chronic unpredictable mild stress increases serum aldosterone without affecting corticosterone levels and induces hepatic steatosis and renal injury in young adult male rats. | J Mol Histol | 2024 | https://conductscience.org/library/papers/38583123 | PubMed |
| 38397012 | Pathophysiology of Diet-Induced Acid Stress. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38397012 | PubMed |
| 38255942 | Potential of Modulating Aldosterone Signaling and Mineralocorticoid Receptor with microRNAs to Attenuate Diabetic Kidney Disease. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38255942 | PubMed |
| 38137561 | A Prospective Study of Eplerenone in the Treatment of Patients with Glomerulonephritis. | Biomedicines | 2023 | https://conductscience.org/library/papers/38137561 | PubMed |
| 38127122 | Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists. | Diabetologia | 2024 | https://conductscience.org/library/papers/38127122 | PubMed |
| 37915899 | Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA). | Clin Kidney J | 2023 | https://conductscience.org/library/papers/37915899 | PubMed |
| 37625003 | Diabetic Nephropathy: Update on Pillars of Therapy Slowing Progression. | Diabetes Care | 2023 | https://conductscience.org/library/papers/37625003 | PubMed |
| 37355590 | Prevalence of uncontrolled hypertension and its associated factors in 50-74 years old Iranian adults: a population-based study. | BMC Cardiovasc Disord | 2023 | https://conductscience.org/library/papers/37355590 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8770880
GET https://conductscience.org/api/papers/v1/8770880/references?page=2